Is durvalumab the solution for unresectable stage III non-small cell lung cancer?

Narjust Duma, Aaron Mansfield, Runzhe Chen

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)S89-S93
JournalTranslational Cancer Research
Volume7
DOIs
StatePublished - Feb 1 2018

Fingerprint

Non-Small Cell Lung Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Is durvalumab the solution for unresectable stage III non-small cell lung cancer? / Duma, Narjust; Mansfield, Aaron; Chen, Runzhe.

In: Translational Cancer Research, Vol. 7, 01.02.2018, p. S89-S93.

Research output: Contribution to journalEditorial

@article{699f7dde1a114b779ebc66b366665c2c,
title = "Is durvalumab the solution for unresectable stage III non-small cell lung cancer?",
author = "Narjust Duma and Aaron Mansfield and Runzhe Chen",
year = "2018",
month = "2",
day = "1",
doi = "10.21037/tcr.2018.01.16",
language = "English (US)",
volume = "7",
pages = "S89--S93",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Is durvalumab the solution for unresectable stage III non-small cell lung cancer?

AU - Duma, Narjust

AU - Mansfield, Aaron

AU - Chen, Runzhe

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85041736272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041736272&partnerID=8YFLogxK

U2 - 10.21037/tcr.2018.01.16

DO - 10.21037/tcr.2018.01.16

M3 - Editorial

AN - SCOPUS:85041736272

VL - 7

SP - S89-S93

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -